Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Operating Expenses | 25,974 | 26,231 | 25,806 | 24,438 | 21,971 |
| Operating Income | -25,974 | -26,231 | -25,806 | -24,438 | -21,971 |
| Other Income | 2,882 | 3,261 | 3,571 | 4,261 | 4,484 |
| Pre-tax Income | -23,092 | -22,970 | -22,235 | -20,177 | -17,487 |
| Net Income Continuous | -23,092 | -22,970 | -22,235 | -20,177 | -17,487 |
| Net Income | $-23,092 | $-22,970 | $-22,235 | $-20,177 | $-17,487 |
| EPS Basic Total Ops | -0.90 | -0.89 | -0.88 | -0.78 | -0.68 |
| EPS Basic Continuous Ops | -0.90 | -0.89 | -0.87 | -0.78 | -0.68 |
| EPS Diluted Total Ops | -0.90 | -0.89 | -0.88 | -0.78 | -0.68 |
| EPS Diluted Continuous Ops | -0.90 | -0.89 | -0.87 | -0.78 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.90 | -0.89 | -0.86 | -0.78 | -0.68 |
| EBITDA(a) | $-27,397 | $-27,781 | $-27,769 | $-26,579 | $-24,251 |